{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:41:01Z","timestamp":1791610861126,"version":"4.3.4"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007156","name":"Innovation and Technology Commission - Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007156","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Amgen Asia Holdings Limited"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiovascular disease (CVD) is the leading cause of mortality and morbidity in China and worldwide while we are lacking in validated primary prevention model specifically for Chinese. To identify CVD high-risk individuals for early intervention, we created and validated a primary prevention risk prediction model, Personalized CARdiovascular DIsease risk Assessment for Chinese (1\u00b0P-CARDIAC), in contemporary Chinese cohorts in Hong Kong.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients without any history of CVD was categorized as derivation and validation cohorts based on their different geographical location of residence in Hong Kong. The outcome was the first diagnosis of a composite of coronary heart disease, ischemic or hemorrhagic stroke, peripheral artery disease, and revascularization. The full model incorporated all available variables in the dataset as clinical laboratory tests, disease and medication history, family history of disease, demographic factors, and healthcare utilization. We employed XGBoost Cox model and multivariate imputation with chained equation (MICE) for derivation and missing data replacement. A basic model was developed with the integration of statistically significant and important subset of risk variables by least absolute shrinkage and selection operator (LASSO) regression. Validation was performed by 1000 bootstrap replicates and compared to four existing models: PREDICT, pooled cohort equation (PCE), China-PAR, and Framingham (Asian).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study included 179,953 patients in the derivation cohort and 1,083,924 patients across two independent validation cohorts. A total of 103 covariates were included in the full model whilst 8 covariates were included the basic model. It demonstrated good performance with C-statistic of 0.87 (95% CI: 0.87, 0.87), calibration slope of 0.94 in the full model. The C-statistic in the basic model was 0.75 (95% CI: 0.75, 0.75) with calibration slope of 0.91. Other comparison risk models have lower C statistic ranging from 0.68 to 0.72.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We developed and validated 1\u00b0P-CARDIAC, a CVD risk prediction model for primary prevention applying a novel hybrid statistical and machine-learning approach. Validation results suggest that it may offer improved performance compared to commonly used risk models. The 1\u00b0P-CARDIAC yields the similar level of accuracy and performance between basic and full model. It demonstrated both effectiveness and versatility in harnessing the power of big data and which has the potential to serve as a promising method for CVD primary prevention and improving public health outcome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0322419","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T17:38:32Z","timestamp":1753724312000},"page":"e0322419","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Primary prevention cardiovascular disease risk prediction model for contemporary Chinese (1\u00b0P-CARDIAC): Model derivation and validation using a hybrid statistical and machine-learning approach"],"prefix":"10.1371","volume":"20","author":[{"given":"Yekai","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia Jiaxi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7895-198X","authenticated-orcid":true,"given":"Joseph Edgar","family":"Blais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Yuk Fai","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5205-9440","authenticated-orcid":true,"given":"Emmanuel","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Chung-Wah","family":"Siu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai Hang","family":"Yiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Wai Yin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tak-Wah","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian Chi Kei","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruibang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1513-8726","authenticated-orcid":true,"given":"Celine S. L.","family":"Chui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"issue":"10015","key":"pone.0322419.ref001","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(15)00551-6","article-title":"Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013","volume":"387","author":"M Zhou","year":"2016","journal-title":"Lancet"},{"issue":"10204","key":"pone.0322419.ref002","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","article-title":"Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"394","author":"M Zhou","year":"2019","journal-title":"Lancet"},{"issue":"10258","key":"pone.0322419.ref003","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","journal-title":"The Lancet"},{"key":"pone.0322419.ref004","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2458-9-30","article-title":"The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing, 1999-2010","volume":"9","author":"J Cheng","year":"2009","journal-title":"BMC Public Health"},{"issue":"2","key":"pone.0322419.ref005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/ejcts\/ezy180","article-title":"Statistical Primer: developing and validating a risk prediction model","volume":"54","author":"SW Grant","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"pone.0322419.ref006","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/jch.14336","article-title":"Cardiovascular risk assessment tools in Asia","volume":"24","author":"Y Zhang","year":"2022","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"1","key":"pone.0322419.ref007","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0002-9149(76)90061-8","article-title":"A general cardiovascular risk profile: the Framingham Study","volume":"38","author":"WB Kannel","year":"1976","journal-title":"Am J Cardiol"},{"issue":"21","key":"pone.0322419.ref008","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1161\/CIRCULATIONAHA.105.607499","article-title":"Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults","volume":"114","author":"Y Wu","year":"2006","journal-title":"Circulation"},{"issue":"19","key":"pone.0322419.ref009","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/CIRCULATIONAHA.116.022367","article-title":"Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China)","volume":"134","author":"X Yang","year":"2016","journal-title":"Circulation"},{"issue":"21","key":"pone.0322419.ref010","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1001\/jama.291.21.2591","article-title":"Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study","volume":"291","author":"J Liu","year":"2004","journal-title":"JAMA"},{"issue":"683","key":"pone.0322419.ref011","doi-asserted-by":"crossref","DOI":"10.3399\/bjgp19X702725","article-title":"Comorbidity in patients with cardiovascular disease in primary care: a cohort study with routine healthcare data","volume":"69","author":"J Buddeke","year":"2019","journal-title":"Br J Gen Pract"},{"issue":"4","key":"pone.0322419.ref012","article-title":"Can machine-learning improve cardiovascular risk prediction using routine clinical data?","volume":"12","author":"SF Weng","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"pone.0322419.ref013","doi-asserted-by":"crossref","first-page":"8886","DOI":"10.1038\/s41598-021-88257-w","article-title":"Pre-existing and machine learning-based models for cardiovascular risk prediction","volume":"11","author":"S-Y Cho","year":"2021","journal-title":"Sci Rep"},{"issue":"13","key":"pone.0322419.ref014","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.2017.18391","article-title":"Big Data and Machine Learning in Health Care","volume":"319","author":"AL Beam","year":"2018","journal-title":"JAMA"},{"issue":"11","key":"pone.0322419.ref015","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/jama.2018.11100","article-title":"Deep Learning-A Technology With the Potential to Transform Health Care","volume":"320","author":"G Hinton","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"pone.0322419.ref016","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41591-018-0320-3","article-title":"A call for deep-learning healthcare","volume":"25","author":"B Norgeot","year":"2019","journal-title":"Nat Med"},{"issue":"1","key":"pone.0322419.ref017","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41591-018-0316-z","article-title":"A guide to deep learning in healthcare","volume":"25","author":"A Esteva","year":"2019","journal-title":"Nat Med"},{"issue":"5","key":"pone.0322419.ref018","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(19)30149-4","article-title":"Big data and machine learning algorithms for health-care delivery","volume":"20","author":"KY Ngiam","year":"2019","journal-title":"Lancet Oncol"},{"issue":"1","key":"pone.0322419.ref019","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S2215-0366(15)00549-0","article-title":"Big data analytics and machine learning: 2015 and beyond","volume":"3","author":"IC Passos","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"pone.0322419.ref020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jamainternmed.2018.7117","article-title":"Deep Learning in Medicine-Promise, Progress, and Challenges","volume":"179","author":"F Wang","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"10133","key":"pone.0322419.ref021","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/S0140-6736(18)30664-0","article-title":"Cardiovascular disease risk prediction equations in 400\u2008000 primary care patients in New Zealand: a derivation and validation study","volume":"391","author":"R Pylypchuk","year":"2018","journal-title":"Lancet"},{"key":"pone.0322419.ref022","first-page":"2935","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"DC Goff","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"pone.0322419.ref023","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/jech.2005.044842","article-title":"Cardiovascular risk prediction tools for populations in Asia","volume":"61","author":"Collaboration Asia Pacific Cohort Studies","year":"2007","journal-title":"J Epidemiol Community Health"},{"key":"pone.0322419.ref024","unstructured":"Hong Kong Hospital Authority. Data Collaboration Lab (Pilot). 2019."},{"key":"pone.0322419.ref025","article-title":"Cardiovascular outcomes associated with use of clarithromycin: population based study","volume":"352","author":"AY Wong","year":"2016","journal-title":"BMJ"},{"issue":"4","key":"pone.0322419.ref026","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/annrheumdis-2021-221571","article-title":"Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong","volume":"81","author":"X Li","year":"2022","journal-title":"Annal Rheumatic Disease"},{"key":"pone.0322419.ref027","doi-asserted-by":"crossref","first-page":"101504","DOI":"10.1016\/j.eclinm.2022.101504","article-title":"Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: A self-controlled case series study","volume":"50","author":"CSL Chui","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"3","key":"pone.0322419.ref028","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/M21-3700","article-title":"Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine\u00a0: A Case-Control Study","volume":"175","author":"FTT Lai","year":"2022","journal-title":"Ann Intern Med"},{"issue":"3","key":"pone.0322419.ref029","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/ehjdh\/ztae018","article-title":"Development and validation of risk prediction model for recurrent cardiovascular events among Chinese: the Personalized CARdiovascular DIsease risk Assessment for Chinese model","volume":"5","author":"Y Zhou","year":"2024","journal-title":"Eur Heart J Digit Health"},{"issue":"2","key":"pone.0322419.ref030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression Models and Life-Tables","volume":"34","author":"DR Cox","year":"1972","journal-title":"J Roy Stat Soc Series B Method"},{"issue":"1","key":"pone.0322419.ref031","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression Shrinkage and Selection Via the Lasso","volume":"58","author":"R Tibshirani","year":"1996","journal-title":"J Roy Stat Soc Series B Method"},{"issue":"3","key":"pone.0322419.ref032","first-page":"1","article-title":"mice: Multivariate Imputation by Chained Equations inR","volume":"45","author":"S van Buuren","year":"2011","journal-title":"J Stat Soft"},{"issue":"282","key":"pone.0322419.ref033","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric Estimation from Incomplete Observations","volume":"53","author":"EL Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"pone.0322419.ref034","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1177\/0962280213497434","article-title":"Assessing calibration of prognostic risk scores","volume":"25","author":"CS Crowson","year":"2016","journal-title":"Stat Methods Med Res"},{"issue":"18","key":"pone.0322419.ref035","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","article-title":"Evaluating the Yield of Medical Tests","volume":"247","author":"FE Harrell","year":"1982","journal-title":"JAMA"},{"issue":"1","key":"pone.0322419.ref036","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","article-title":"Calibration: the Achilles heel of predictive analytics","volume":"17","author":"B Van Calster","year":"2019","journal-title":"BMC Med"},{"issue":"1","key":"pone.0322419.ref037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1175\/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2","article-title":"Verification of forecasts expressed in terms of probability","volume":"78","author":"GW Brier","year":"1950","journal-title":"Monthly Weather Rev"},{"issue":"1","key":"pone.0322419.ref038","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the performance of prediction models: a framework for traditional and novel measures","volume":"21","author":"EW Steyerberg","year":"2010","journal-title":"Epidemiology"},{"key":"pone.0322419.ref039","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1472-6947-8-53","article-title":"Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers","volume":"8","author":"AJ Vickers","year":"2008","journal-title":"BMC Med Inform Decis Mak"},{"issue":"6","key":"pone.0322419.ref040","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"AJ Vickers","year":"2006","journal-title":"Med Decis Making"},{"issue":"1","key":"pone.0322419.ref041","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","article-title":"From Local Explanations to Global Understanding with Explainable AI for Trees","volume":"2","author":"SM Lundberg","year":"2020","journal-title":"Nat Mach Intell"},{"issue":"40","key":"pone.0322419.ref042","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.21105\/joss.01317","article-title":"lifelines: survival analysis in Python","volume":"4","author":"C Davidson-Pilon","year":"2019","journal-title":"JOSS"},{"key":"pone.0322419.ref043","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPODstatement"},{"issue":"4","key":"pone.0322419.ref044","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/01.CIR.0000136583.52681.0D","article-title":"Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China","volume":"110","author":"J He","year":"2004","journal-title":"Circulation"},{"issue":"11","key":"pone.0322419.ref045","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/M16-1739","article-title":"Calibration of the Pooled Cohort Equations for Atherosclerotic Cardiovascular Disease: An Update","volume":"165","author":"NR Cook","year":"2016","journal-title":"Ann Intern Med"},{"issue":"9","key":"pone.0322419.ref046","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/hrt.2010.220442","article-title":"Cardiovascular risk scores do not account for the effect of treatment: a review","volume":"97","author":"SM Liew","year":"2011","journal-title":"Heart"},{"key":"pone.0322419.ref047","article-title":"Inflammation as a cardiovascular risk factor","volume":"109","author":"JT Willerson","year":"2004","journal-title":"Circulation"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0322419","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T17:38:43Z","timestamp":1753724323000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0322419"}},"subtitle":[],"editor":[{"given":"Thien Tan Tri Tai","family":"Truyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":47,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0322419","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]}}}